MARKET

AGN

Allergan
AGN
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
-12.0477
3.947
1.090
63,651,343,951.74
Fitch Affirms Teva at 'BB-'; Outlook Remains Negative
reuters.com · 02/26 19:30
AbbVie revenue beats expectations on Humira demand
reuters.com · 02/03 12:40
InMode Sets 2020 Stretch Goal To Exceed 2019 Revenue
InMode went public in August, 2019, raising $70 million.The firm sells medical aesthetic technologies in the U.S. and overseas.INMD suffered the full effects of the Covid-19 pandemic and electric surgery shutdown, but has wisely managed for the long term.Management believes it can equal or slightly exceed 2019's revenue in 2020 despite the sharp industry contraction in Q1, so I'm Bullish on the stock.
Seekingalpha · 08/16/2020 16:13
AbbVie Joins The Coronavirus Drug Hunt — Is AbbVie Stock A Buy?
AbbVie stock broke out in April and the pharmaceutical company just wrapped its acquisition of Allergan. Further, AbbVie is collaborating on a coronavirus drug. Is AbbVie stock a buy now?
Investor's Business Daily · 07/27/2020 12:00
Importance Of Education In CBD Market (Podcast Transcript)
Seeking Alpha - Article · 07/12/2020 12:20
Importance Of Education In CBD Market (Podcast)
Seeking Alpha - Article · 07/08/2020 13:00
Cannabis Investors May Be Overlooking This Part Of The Market
Seeking Alpha - Article · 07/07/2020 13:12
Cannabis Investors Should Be Looking For Good Stewards Of Capital (Podcast)
Seeking Alpha - Article · 07/01/2020 13:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AGN. Analyze the recent business situations of Allergan through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AGN stock price target is 188.33 with a high estimate of 203.00 and a low estimate of 157.00.
EPS
Institutional Holdings
Institutions: 1.09K
Institutional Holdings: 283.44M
% Owned: 85.95%
Shares Outstanding: 329.77M
TypeInstitutionsShares
Increased
268
32.52M
New
147
10.42M
Decreased
418
29.28M
Sold Out
161
9.96M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.39%
Pharmaceuticals & Medical Research
-0.46%
Key Executives
Chairman/President/Chief Executive Officer/Director
Brenton Saunders
Chief Financial Officer/Executive Vice President
Matthew Walsh
Chief Human Resource Officer/Executive Vice President
Karen Ling
Executive Vice President/Secretary
A. Robert Bailey
Executive Vice President
William Meury
Executive Vice President
C.David Nicholson
Other
C. Nicholson
Executive Vice President
Wayne Swanton
Chief Accounting Officer
James D'Arecca
Lead Director/Independent Director
Christopher Coughlin
Independent Director
Nesli Basgoz
Independent Director
Joseph Boccuzi
Independent Director
Christopher Bodine
Independent Director
Adriane Brown
Independent Director
Carol Davidson
Independent Director
Thomas Freyman
Independent Director
Michael Greenberg
Independent Director
Robert Hugin
Independent Director
Peter McDonnell
Declaration Date
Dividend Per Share
Ex-Div Date
03/18/2020
Dividend USD 0.74
04/15/2020
01/24/2020
Dividend USD 0.74
02/13/2020
10/25/2019
Dividend USD 0.74
11/12/2019
07/19/2019
Dividend USD 0.74
08/12/2019
05/03/2019
Dividend USD 0.74
05/13/2019
01/25/2019
Dividend USD 0.74
02/14/2019
10/26/2018
Dividend USD 0.72
11/09/2018
07/30/2018
Dividend USD 0.72
08/16/2018
05/03/2018
Dividend USD 0.72
05/17/2018
02/09/2018
Dividend USD 0.72
02/27/2018
10/27/2017
Dividend USD 0.7
11/16/2017
08/02/2017
Dividend USD 0.7
08/16/2017
05/10/2017
Dividend USD 0.7
05/16/2017
02/07/2017
Dividend USD 0.7
02/24/2017
02/06/2015
Dividend USD 0.05
02/25/2015
02/05/2015
Dividend USD 0.05
02/05/2015
10/27/2014
Dividend USD 0.05
11/18/2014
07/21/2014
Dividend USD 0.05
08/13/2014
05/07/2014
Dividend USD 0.05
05/21/2014
02/05/2014
Dividend USD 0.05
02/26/2014

Webull offers kinds of Allergan stock information, including NYSE:AGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGN stock methods without spending real money on the virtual paper trading platform.